This week's episode provides a roadmap for creating a culture of high-quality Afib care within a health system. We'll discuss the importance of anticoagulant therapy and Afib management education outside of the electrophysiology and cardiology teams, how this education is reflected in other care settings, and how this can be replicated.

This week's episode provides insight into the process of successfully implementing an EHR solution within a health system with the goal of improving medication education for anticoagulant therapy in Afib patients. We will team pharmacy's role, workflows, dosing, monitoring, and education tracking.

The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.

The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.

The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.

The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.

This episode explores the medications involved in treating hyperlipidemia-related ASCVD from a pharmacist perspective and the common patient misconceptions surrounding these interventions.

Speaker:

Megan Supple, PharmD, BCACP, CPP

Ambulatory Care Pharmacist

Cone Health Medical Group Cardiovascular Division

This episode examines the most common patient perceived barriers to treatment and management strategies to overcome these situations in the outpatient/clinic setting.

Speaker:

Kevin Hwang, MD

Associate Professor of Internal Medicine at McGovern Medical School

Medical Director, UT General Internal Medicine clinic in the Texas Medical Center

This episode evaluates pathways to identify adults with high ASCVD risk and intervention with lipid-lowering therapy in the Emergency Department.

Speaker:

James Langabeer, MD

Professor of Emergency Medicine

Vice Chair- Population Health

This episode lays the groundwork for our understanding of ASCVD lipid management. Our guest will walk through the algorithm for treatment to guidelines as well as address the barriers, pitfalls, and potential solutions in managing care.

Speaker:

Dr. Murtuza Ali ,MD

Professor of Clinical Medicine

Program Director- Interventional Cardiology Fellowship

Louisiana State University School of Medicine